AR and prostate carcinoma: For example, Cloos et al. [142] showed that JmjD2A, B and C are increased in prostate cancer tissues followed by studies demonstrating KDM4 enzymes to be coactivators of the androgen receptor [143,144], in addition to roles in androgen independent proliferation of prostate cancer cells [145].